Plexus Corp. (NASDAQ:PLXS) Receives Consensus Recommendation of “Moderate Buy” from Analysts

Plexus Corp. (NASDAQ:PLXSGet Free Report) has been assigned an average recommendation of “Moderate Buy” from the seven research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have issued a buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $238.3333.

Several equities research analysts have recently commented on the company. Zacks Research downgraded Plexus from a “hold” rating to a “strong sell” rating in a report on Wednesday, May 20th. Wall Street Zen upgraded shares of Plexus from a “hold” rating to a “buy” rating in a report on Saturday, May 2nd. Weiss Ratings lowered shares of Plexus from a “buy (b)” rating to a “buy (b-)” rating in a research report on Thursday. Needham & Company LLC increased their price target on shares of Plexus from $285.00 to $310.00 and gave the company a “buy” rating in a research note on Monday, June 1st. Finally, Stifel Nicolaus set a $280.00 price objective on shares of Plexus in a research note on Tuesday, May 26th.

View Our Latest Report on PLXS

Insider Activity

In other Plexus news, EVP Angelo Michael Ninivaggi, Jr. sold 3,270 shares of the company’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $264.75, for a total value of $865,732.50. Following the sale, the executive vice president owned 16,266 shares in the company, valued at $4,306,423.50. This represents a 16.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Michael J. Running sold 510 shares of the firm’s stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $272.17, for a total value of $138,806.70. Following the completion of the sale, the insider directly owned 665 shares of the company’s stock, valued at approximately $180,993.05. The trade was a 43.40% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders have sold 21,981 shares of company stock valued at $5,704,208. Company insiders own 1.78% of the company’s stock.

Institutional Investors Weigh In On Plexus

Large investors have recently added to or reduced their stakes in the business. Glenmede Trust Co. NA lifted its holdings in Plexus by 14.3% during the 1st quarter. Glenmede Trust Co. NA now owns 2,329 shares of the technology company’s stock valued at $472,000 after purchasing an additional 292 shares during the last quarter. Bank of America Corp DE increased its holdings in shares of Plexus by 0.3% in the first quarter. Bank of America Corp DE now owns 175,832 shares of the technology company’s stock valued at $35,613,000 after purchasing an additional 573 shares during the last quarter. Intrinsic Edge Capital Management LLC bought a new position in shares of Plexus in the first quarter valued at about $4,253,000. Smith Group Asset Management LLC lifted its stake in shares of Plexus by 9.3% during the 1st quarter. Smith Group Asset Management LLC now owns 4,830 shares of the technology company’s stock worth $978,000 after buying an additional 409 shares during the last quarter. Finally, Amundi lifted its stake in shares of Plexus by 143.0% during the 1st quarter. Amundi now owns 31,294 shares of the technology company’s stock worth $6,338,000 after buying an additional 18,418 shares during the last quarter. Institutional investors own 94.45% of the company’s stock.

Plexus Price Performance

NASDAQ:PLXS opened at $295.02 on Monday. The stock’s 50-day simple moving average is $253.52 and its 200 day simple moving average is $204.93. Plexus has a 52-week low of $115.35 and a 52-week high of $299.00. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.74 and a current ratio of 1.54. The company has a market cap of $7.89 billion, a P/E ratio of 43.13 and a beta of 0.89.

Plexus (NASDAQ:PLXSGet Free Report) last posted its quarterly earnings results on Wednesday, April 29th. The technology company reported $2.05 earnings per share for the quarter, beating analysts’ consensus estimates of $1.87 by $0.18. The firm had revenue of $1.16 billion during the quarter, compared to the consensus estimate of $1.13 billion. Plexus had a return on equity of 12.84% and a net margin of 4.35%.The business’s revenue was up 18.7% compared to the same quarter last year. During the same period last year, the company earned $1.66 earnings per share. Plexus has set its Q3 2026 guidance at 2.020-2.180 EPS. As a group, sell-side analysts forecast that Plexus will post 5.98 EPS for the current fiscal year.

About Plexus

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

See Also

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.